Search results
Kite and Arcellx to start Phase 3 trial for myeloma therapy By Investing.com
Investing.com· 1 day agoAnito-cel, which utilizes Arcellx’s novel D-Domain binder, is a BCMA CAR T-cell therapy, a type of...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 1 week agoDelhi, May 01, 2024 (GLOBE NEWSWIRE) -- Global CD70 Targeting Therapies Market Opportunity & Clinical Trials Insight 2024 Report Highlights: CD70 Targeting Therapies In Clinical Trials: > 20 TherapiesCD 70 Targeting Therapies Clinical Trials
AstraZeneca’s Fasenra: Approval for asthma may initiate COPD approval
Pharmaceutical Technology via Yahoo Finance· 2 weeks agoFasenra is a monoclonal antibody that inhibits the alpha subunit of the interleukin-5 receptor found...
Pipeline Moves: Investigator-led trial of Lilly’s merestinib in solid tumours terminated
Clinical Trials Arena via Yahoo Finance· 2 weeks agoThe Phase I study ended on 13 March. Calpurbatug is an intravenous monoclonal antibody therapy that...
BIOSECURE bill targets more Chinese companies as biotechs and their customers adapt to defunding
Pharmaceutical Technology via Yahoo Finance· 2 weeks agoUS lawmakers have added more Chinese biotech and medtech companies to the list of firms posing...
FDA prioritizes review of Merus's cancer therapy Zeno By Investing.com
Investing.com· 4 days agoThe U.S. Food and Drug Administration (FDA) has granted a priority review for the Biologics License...
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 week agoArbutus Biopharma Corporation (NASDAQ:ABUS) Q1 2024 Earnings Call Transcript May 2, 2024 Arbutus...
Earnings call: TG Therapeutics sees strong Q1 growth with Briumvi
Investing.com· 1 week agoTG Therapeutics (NASDAQ: TGTX ) has reported a robust first quarter in 2024, with Briumvi, its...
Earnings call: Enanta Pharmaceuticals Q2 fiscal results and pipeline updates
Investing.com· 4 days agoEnanta Pharmaceuticals ( NASDAQ : NASDAQ: ENTA ), a biopharmaceutical company focused on developing...
Elrexfio and dosage: Strengths, form, when to use, and more
Medical News Today· 4 days agoElrexfio (elranatamab-bcmm) is a brand-name drug that’s prescribed for specific cases of multiple...